Balow JE - Search Results

1

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL. Austin HA 3rd, et al. Among authors: balow je. N Engl J Med. 1986 Mar 6;314(10):614-9. doi: 10.1056/NEJM198603063141004. N Engl J Med. 1986. PMID: 3511372 Clinical Trial.

2

Maintenance therapy for lupus nephritis--something old, something new.

Balow JE, Austin HA 3rd. Balow JE, et al. N Engl J Med. 2004 Mar 4;350(10):1044-6. doi: 10.1056/NEJMe048010. N Engl J Med. 2004. PMID: 14999117 No abstract available.

3

Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.

Carette S, Klippel JH, Decker JL, Austin HA, Plotz PH, Steinberg AD, Balow JE. Carette S, et al. Among authors: balow je. Ann Intern Med. 1983 Jul;99(1):1-8. doi: 10.7326/0003-4819-99-1-1. Ann Intern Med. 1983. PMID: 6344715 Clinical Trial.

4

Prognostic factors in lupus nephritis. Contribution of renal histologic data.

Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE. Austin HA 3rd, et al. Among authors: balow je. Am J Med. 1983 Sep;75(3):382-91. doi: 10.1016/0002-9343(83)90338-8. Am J Med. 1983. PMID: 6351607 Clinical Trial.

5

Effect of treatment on the evolution of renal abnormalities in lupus nephritis.

Balow JE, Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Klippel JH, Steinberg AD, Plotz PH, Decker JL. Balow JE, et al. N Engl J Med. 1984 Aug 23;311(8):491-5. doi: 10.1056/NEJM198408233110802. N Engl J Med. 1984. PMID: 6749206

6

Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.

Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD. Dinant HJ, et al. Among authors: balow je. Ann Intern Med. 1982 Jun;96(6 Pt 1):728-36. doi: 10.7326/0003-4819-96-6-728. Ann Intern Med. 1982. PMID: 7046543 Clinical Trial.

7

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE. Boumpas DT, et al. Among authors: balow je. Lancet. 1992 Sep 26;340(8822):741-5. doi: 10.1016/0140-6736(92)92292-n. Lancet. 1992. PMID: 1356175 Clinical Trial.

8

Therapy of membranous nephropathy in systemic lupus erythematosus.

Balow JE, Austin HA 3rd. Balow JE, et al. Semin Nephrol. 2003 Jul;23(4):386-91. doi: 10.1016/s0270-9295(03)00056-1. Semin Nephrol. 2003. PMID: 12923727 Review.

9

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Boumpas DT, et al. Among authors: balow je. Ann Intern Med. 1993 Sep 1;119(5):366-9. doi: 10.7326/0003-4819-119-5-199309010-00003. Ann Intern Med. 1993. PMID: 8338289 Clinical Trial.

10

High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients.

Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Austin HA 3rd, et al. Among authors: balow je. Nephrol Dial Transplant. 1995;10(9):1620-8. Nephrol Dial Transplant. 1995. PMID: 8559480 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters